Historical record - last NADAC effective date: 6/19/2024
Product Information
CHILD MUCINEX MULTI-SYMPTOM LQ is a brand product labeled by RB Health (US) LLC, priced at $0.0704 per ML under NDC 63824094901. Its NADAC has been published 62 times since Jul 21, 2021.
CHILD MUCINEX MULTI-SYMPTOM LQ
Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine HydrochlorideStrength
5; 100; 2.5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
RB Health (US) LLCNDC
63824094901
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/30/2018
Pharmacological Classes
Price Statistics
The NADAC for CHILD MUCINEX MULTI-SYMPTOM LQ has been published 62 times since Jul 21, 2021, and over the history we have for it it has risen 14.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0704 per ML |
|---|---|
| All-time high | $0.0716 (May 15, 2024) |
| All-time low | $0.0615 (Jul 21, 2021) |
| Median price | $0.0626 |
| Average price | $0.0655 |
| Largest weekly change | +11.8% (Apr 6, 2022) |
| Weeks tracked | 62 |
| Tracking since | Jul 21, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+0.6%
5Y
+14.6%
All
+14.6%
Last surveyed Jul 3, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHILD MUCINEX MULTI-SYMPTOM LQ?
The current National Average Drug Acquisition Cost (NADAC) for CHILD MUCINEX MULTI-SYMPTOM LQ, manufactured by RB Health (US) LLC, is $0.0704 per ML (NDC 63824094901), effective Jul 3, 2024.
How has the price of CHILD MUCINEX MULTI-SYMPTOM LQ changed over time?
Over the history we have for it, the NADAC for CHILD MUCINEX MULTI-SYMPTOM LQ has risen 14.6%. It has been tracked across 62 weekly CMS publications since Jul 21, 2021.
What are the highest and lowest recorded NADAC prices for CHILD MUCINEX MULTI-SYMPTOM LQ?
Since Jul 21, 2021, the NADAC for CHILD MUCINEX MULTI-SYMPTOM LQ has ranged from a low of $0.0615 (Jul 21, 2021) to a high of $0.0716 (May 15, 2024), with a median of $0.0626 per ML.
Are there cheaper alternatives to CHILD MUCINEX MULTI-SYMPTOM LQ?
No other NADAC-published product currently shares the active ingredient and strength of CHILD MUCINEX MULTI-SYMPTOM LQ in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHILD MUCINEX MULTI-SYMPTOM LQ?
CHILD MUCINEX MULTI-SYMPTOM LQ (NDC 63824094901) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.